For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of Tafamidis and Attruby represents a true change. These groundbreaking therapies preserve the https://attrcm716612.tribunablog.com/a-significant-attr-cm-breakthrough-the-drug-and-attruby-provide-hope-56856329